πŸ‡ΊπŸ‡Έ FDA
Patent

US 8344019

Methods for the production of biliverdin

granted A61PA61P25/28A61P29/00

Quick answer

US patent 8344019 (Methods for the production of biliverdin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P25/28, A61P29/00, A61P35/00, A61P9/00